CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | Bishop John E See Remarks | Sale | −2,469 | $3.86 | $10K | 317,095 |
| 2026-07-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,834 | $0.99 | $21K | 1,720,034 |
| 2026-07-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,668 | $5.06 | $211K | 1,678,366 |
| 2026-07-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,834 | 290,834 | ||
| 2026-06-18 | Williams Laura A Chief Patient Officer | Option exercise 10b5-1 | +31,000 | $0.99 | $31K | 460,093 |
| 2026-06-18 | Williams Laura A Chief Patient Officer | Sale 10b5-1 | −81,898 | $5.99 | $490K | 378,195 |
| 2026-06-18 | Williams Laura A Chief Patient Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −31,000 | 31,000 | ||
| 2026-06-16 | Bhanji Muna Director | Grant or award | +26,455 | 163,808 | ||
| 2026-06-16 | Bhanji Muna Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 | ||
| 2026-06-16 | Cadoret-Manier Onaiza Director | Grant or award | +26,455 | 178,156 | ||
| 2026-06-16 | Cadoret-Manier Onaiza Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 | ||
| 2026-06-16 | Parsey Merdad Director | Grant or award | +26,455 | 83,746 | ||
| 2026-06-16 | Parsey Merdad Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 | ||
| 2026-06-16 | Bazemore Robert B Director | Grant or award | +26,455 | 68,006 | ||
| 2026-06-16 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 | ||
| 2026-06-16 | Rodgers Richard J Director | Grant or award | +26,455 | 439,998 | ||
| 2026-06-16 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 | ||
| 2026-06-16 | Bertrand William C JR Director | Grant or award | +12,345 | 303,052 | ||
| 2026-06-16 | Bertrand William C JR Director | Grant or award | +26,455 | 329,507 | ||
| 2026-06-16 | Bertrand William C JR Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 |
Page 2 of 11 · 206 trades